Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 453 across all filing types
Latest filing 2023-07-06 Share Issue/Capital Cha…
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - LGP 4 pages 23.9KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification about the cessation of certain securities (share rights) for LITTLE GREEN PHARMA LTD. It details the number of securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is an announcement of changes in the company's issued capital related to securities ceasing to exist or lapsing. It does not contain financial statements, management discussion, or detailed financial results. It is not a full report but a regulatory announcement about capital changes. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is 3584 characters, which is consistent with an announcement rather than a full report.
2023-07-06 English
Reset Mind Sciences signs long-term property lease 2 pages 378.9KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 3 July 2023 regarding Reset Mind Sciences signing a long-term lease for a property with office, clinic, and GMP manufacturing facilities. It discusses strategic business operations and lease terms but contains no financial statements, earnings data, or regulatory filings. It is not a report, earnings release, or management discussion. It is a corporate announcement about a lease agreement, which relates to capital or operational updates but not financing or capital structure changes. The document is informational about a business lease arrangement and does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is Capital/Financing Update (CAP) as it relates to a significant lease agreement impacting company operations and capital commitments. Confidence is high given the content and nature of the announcement.
2023-07-02 English
Corporate Governance Statement and Appendix 4G 31 pages 560.9KB
Governance Information Classification · 95% confidence The document is titled 'Corporate Governance Statement' and extensively discusses the company's governance practices, board composition, roles and responsibilities, diversity policies, and related governance principles. It references compliance with ASX Corporate Governance Principles and Recommendations. There is no indication of financial statements, audit results, earnings data, or other financial performance details. The content is focused on governance structure and policies rather than financial reporting or announcements. Therefore, this document fits the category of Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is a full governance report, not a brief announcement or summary.
2023-06-29 English
Annual Report to shareholders 96 pages 13.8MB
Regulatory Filings
2023-06-29 English
Preliminary Final Report 37 pages 2.2MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Appendix 4E' and is for the year ended 31 March 2023. Appendix 4E is a standard Australian Securities Exchange (ASX) reporting form used for preliminary final reports, which typically include unaudited financial results and operational performance summaries. The document contains detailed financial data such as revenue, loss before and after tax, net tangible assets, and operational highlights. It also includes an independent auditor's report section indicating the financial report is in the process of being audited. The document is approximately 15,000 characters long, indicating it is a substantive financial report rather than a brief announcement. The content includes comprehensive financial statements and management discussion, consistent with an Interim / Quarterly Report or Annual Report. However, since the reporting period is a full fiscal year ending 31 March 2023, and the document is an Appendix 4E (preliminary final report), it aligns with an Interim / Quarterly Report (IR) in the Australian context, as Appendix 4E is used for preliminary final reports before the full Annual Report (10-K equivalent) is released. Therefore, the most appropriate classification is Interim / Quarterly Report (IR). FY 2023
2023-05-30 English
LGP wins extended French government tender 3 pages 336.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 8 May 2023 from Little Green Pharma Ltd. It details the company's re-appointment as a primary supplier for the extended French government medicinal cannabis trial. The content focuses on business updates, contract awards, market strategy, and partnership details. There are no financial statements, quarterly or annual results, nor any regulatory certifications or voting results. The document is a corporate announcement about a contract win and strategic positioning rather than a financial report or regulatory filing. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. Therefore, the document best fits the category of a general regulatory announcement or compliance document that does not fit other specific categories, which corresponds to Regulatory Filings (RNS).
2023-05-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.